Navigation Links
AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
Date:3/5/2008

BENICIA, Calif., March 5 /PRNewswire/ -- AcroMetrix, a global leader in quality control materials and standards for molecular and serological diagnostics, announced today that it has entered into an agreement with Beckman Coulter Inc. for the development and supply of molecular quality control standards for various molecular targets.

AcroMetrix provides In Vitro Diagnostic manufacturers and clinical laboratories with quality control products for molecular testing of infectious disease, oncology, and genetics. These products provide a means by which to establish and monitor assay performance and estimate accuracy and detect systematic errors in molecular diagnostic assays.

"This agreement demonstrates the importance of quality control and standardization in molecular diagnostic testing. We are excited to be working with Beckman Coulter, a leader in the In Vitro Diagnostic industry," said Michael J. Eck, President and CEO for AcroMetrix.

The agreement includes the initial development and supply of quality control standards for 10 molecular targets that will be used in the development of Beckman Coulter's molecular UniCel DxN instrument. This agreement was made possible through AcroMetrix' Contract Manufacturing department which provides customers with high quality, tailored solutions enabling customers to benefit on the years of experience developed by AcroMetrix in the field of molecular quality control materials.

About AcroMetrix - AcroMetrix, with facilities in Benicia, California and Alkmaar, the Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in clinical diagnostics and blood screening laboratories. For more information on AcroMetrix please visit the company web site at http://www.acrometrix.com.


'/>"/>
SOURCE AcroMetrix
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Touch Bionics signs U.S. distribution agreement with SPS
2. Martek Signs Multi-Year Sole-Source Supply Agreement with Numico
3. The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions
4. Enigma Signs Real-Time PCR Licences With Applera
5. Foamix Signs Term Sheet to Acquire License to Organo-Boron Antifungal Molecules - Will Target the $11 Billion Dollars Fungal Infection Market
6. SemBioSys signs option agreement for safflower-produced food ingredient
7. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
8. Protalix BioTherapeutics Signs Lease Agreement for Expansion of its Manufacturing and Research Facility in Carmiel, Israel
9. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
10. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
11. Kiwa Signs Letter of Intent with Huaxing Animal Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 24, 2017  Asterias Biotherapeutics, Inc. ... field of regenerative medicine, today announced positive efficacy ... clinical trial that showed additional motor function improvement ... million AST-OPC1 cells in AIS-A patients with complete ... of upper extremity motor function is critically important ...
(Date:1/24/2017)... Switerland (PRWEB) , ... January 24, 2017 , ... ... first commercially available malaria Plasmodium falciparum culture panels with standard concentrations of histidine ... which are available in a range of concentrations from six different malaria strains, ...
(Date:1/24/2017)... , ... January 23, 2017 , ... Oklahoma City based ... newest client for the firm’s PERFEQTA software and legacy product QC Manager 2.0. ... the dynamic team at CJBC and thrilled that they have decided to implement PERFEQTA ...
(Date:1/24/2017)... , Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... into an underwriting agreement with Rodman & Renshaw, a ... as sole book running manager and representative of several underwriters, ... a firm commitment basis a minimum of 2,105,264 shares ... to purchase a minimum of 1,052,632 shares of common ...
Breaking Biology Technology:
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
Breaking Biology News(10 mins):